(Q51788532)

12 April 2018

title

Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS. (English)

1 reference

12 April 2018

author name string

Hongyan Li

1

1 reference

12 April 2018

Mark J Rose

2

1 reference

12 April 2018

Linh Tran

3

1 reference

12 April 2018

Jingwen Zhang

4

1 reference

12 April 2018

Les P Miranda

5

1 reference

12 April 2018

Christopher A James

6

1 reference

12 April 2018

Barbra J Sasu

7

1 reference

12 April 2018

publication date

28 February 2009

1 reference

12 April 2018

Journal of Pharmacological and Toxicological Methods

published in

1 reference

12 April 2018

volume

59

1 reference

12 April 2018

issue

3

1 reference

12 April 2018

page(s)

171-180

1 reference

12 April 2018

describes a project that uses

liquid chromatography–mass spectrometry

1 reference

based on heuristic

inferred from title

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

cites work

Relationship between intestinal iron-transporter expression, hepatic hepcidin levels and the control of iron absorption

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Anemia of inflammation: the cytokine-hepcidin link

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Online immunoaffinity liquid chromatography/tandem mass spectrometry determination of a type II collagen peptide biomarker in rat urine: Investigation of the impact of collision-induced dissociation fluctuation on peptide quantitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

LC-MS/MS quantification of Zn-alpha2 glycoprotein: a potential serum biomarker for prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Simultaneous determination of myristyl nicotinate, nicotinic acid, and nicotinamide in rabbit plasma by liquid chromatography-tandem mass spectrometry using methyl ethyl ketone as a deproteinization solvent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Quantification of uric acid, xanthine and hypoxanthine in human serum by HPLC for pharmacodynamic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Relevance of C-reactive protein levels in peritoneal dialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Iron imports. IV. Hepcidin and regulation of body iron metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Immunoassay for human serum hepcidin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Plasma prohepcidin positively correlates with hematocrit in chronic hemodialysis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Liquid chromatography/tandem mass spectrometry characterization of oxidized amyloid beta peptides as potential biomarkers of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

The application of ultra-performance liquid chromatography/tandem mass spectrometry to the detection and quantitation of apolipoproteins in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Development and validation of an LC/MS/MS procedure for the quantification of endogenous myo-inositol concentrations in rat brain tissue homogenates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Development of an absolute quantification method targeting growth hormone biomarkers using liquid chromatography coupled to isotope dilution mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Quantification of hepcidin-25 in human serum by isotope dilution micro-HPLC-tandem mass spectrometry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Clinical validation of an immunoaffinity LC-MS/MS assay for the quantification of a collagen type II neoepitope peptide: A biomarker of matrix metalloproteinase activity and osteoarthritis in human urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Hepcidin, a urinary antimicrobial peptide synthesized in the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Factors predicting malnutrition in hemodialysis patients: a cross-sectional study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

2002 E. Mead Johnson Award for Research in Pediatrics Lecture: the molecular biology of the anemia of chronic disease: a hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

An Hfe-dependent pathway mediates hyposideremia in response to lipopolysaccharide-induced inflammation in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Prohepcidin accumulates in renal insufficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

SELDI-TOF-MS determination of hepcidin in clinical samples using stable isotope labelled hepcidin as an internal standard

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Mass spectrometry-based expression profiling of clinical prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

Inflammation enhances cardiovascular risk and mortality in hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2009.02.004

10.1016/J.VASCN.2009.02.004

7 January 2021

Identifiers

DOI

1 reference

12 April 2018

1 reference

12 April 2018